1 |
Yang, Y., Zhu, X., Chen, Y., Wang, X. and Chen, R. 2007. p38 and JNK MAPK, but not ERK1/2 MAPK, play important role in colchicine-induced cortical neurons apoptosis. Eur. J. Pharmacol. 576, 26-33.
DOI
|
2 |
Pica, F., Balestrieri, E., Serafino, A., Sorrentino, R., Gaziano, R., Moroni, G., Moroni, N., Palmieri, G., Mattei, M., Garaci, E. and Sinibaldi-Vallebona, P. 2012. Antitumor effects of the benzophenanthridine alkaloid sanguinarine in a rat syngeneic model of colorectal cancer. Anticancer Drugs 23, 32-42.
DOI
|
3 |
Slunská, Z., Gelnarová, E., Hammerová, J., Táborská, E. and Slaninová, I. 2010. Effect of quaternary benzo[c]phenanthridine alkaloids sanguilutine and chelilutine on normal and cancer cells. Toxicol. In Vitro 24, 697-706.
DOI
|
4 |
Sun, M., Liu, C., Nadiminty, N., Lou, W., Zhu, Y., Yang, J., Evans, C. P., Zhou, Q. and Gao, A. C. 2012. Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion. Prostate 72, 82-89.
DOI
|
5 |
Toker, A. and Yoeli-Lerner, M. 2006. Akt signaling and cancer: surviving but not moving on. Cancer Res. 66, 3963-3966.
DOI
|
6 |
Vlachojannis, C., Magora, F. and Chrubasik, S. 2012. Rise and fall of oral health products with Canadian bloodroot extract. Phytother. Res. 26, 1423-1426.
|
7 |
Vogt, A., Tamewitz, A., Skoko, J., Sikorski, R. P., Giuliano, K. A. and Lazo, J. S. 2005. The benzo[c]phenanthridine alkaloid, sanguinarine, is a selective, cell-active inhibitor of mitogen-activated protein kinase phosphatase-1. J. Biol. Chem. 280, 19078-19086.
DOI
|
8 |
Weerasinghe, P., Hallock, S., Tang, S. C., Trump, B. and Liepins, A. 2006. Sanguinarine overcomes P-glycoprotein-mediatedmultidrug-resistance via induction of apoptosis and oncosis in CEM-VLB 1000 cells. Exp. Toxicol. Pathol. 58, 21-30.
DOI
|
9 |
Xu, J. Y., Meng, Q. H., Chong, Y., Jiao, Y., Zhao, L., Rosen, E. M. and Fan, S. 2012. Sanguinarine inhibits growth of human cervical cancer cells through the induction of apoptosis. Oncol. Rep. 28, 2264-2270.
|
10 |
Jourdain, A. and Martinou, J. C. 2009. Mitochondrial outer-membrane permeabilization and remodelling in apoptosis. Int. J. Biochem. Cell Biol. 41, 1884-1889.
DOI
|
11 |
Kadenbach, B., Arnold, S., Lee, I. and Hüttemann, M. 2004. The possible role of cytochrome c oxidase in stress-induced apoptosis and degenerative diseases. Biochim. Biophys. Acta. 1655, 400-408.
DOI
|
12 |
Kim, S., Lee, T. J., Leem, J., Choi, K. S., Park, J. W. and Kwon, T. K. 2008. Sanguinarine-induced apoptosis: generation of ROS, down-regulation of Bcl-2, c-FLIP, and synergy with TRAIL. J. Cell. Biochem. 104, 895-907.
DOI
|
13 |
Laster, L. L. and Lobene, R. R. 1990. New perspectives on Sanguinaria clinicals: individual toothpaste and oral rinse testing. J. Can. Dent. Assoc. 56, 19-30.
|
14 |
Lee, J. S., Jung, W. K., Jeong, M. H., Yoon, T. R. and Kim, H. K. 2012. Sanguinarine induces apoptosis of HT-29 human colon cancer cells via the regulation of Bax/Bcl-2 ratio and caspase-9-dependent pathway. Int. J. Toxicol. 31, 70-77.
DOI
|
15 |
Mackraj, I., Govender, T. and Gathiram, P. 2008. Sanguinarine. Cardiovasc. Ther. 26, 75-83.
|
16 |
Park, H., Bergeron, E., Senta, H., Guillemette, K., Beauvais, S., Blouin, R., Sirois, J. and Faucheux, N. 2010. Sanguinarine induces apoptosis of human osteosarcoma cells through the extrinsic and intrinsic pathways. Biochem. Biophys. Res. Commun. 399, 446-451.
DOI
|
17 |
Han, M. H., Yoo, Y. H. and Choi, Y. H. 2008. Sanguinarine-induced apoptosis in human leukemia U937 cells via Bcl-2 downregulation and caspase-3 activation. Chemotherapy 54,157-165.
DOI
|
18 |
Park, S. Y., Jin, M. L., Kim, Y. H., Lee, S. J. and Park, G. 2014. Sanguinarine inhibits invasiveness and the MMP-9 and COX-2 expression in TPA-induced breast cancer cells by inducing HO-1 expression. Oncol. Rep. 31, 497-504.
|
19 |
Gupta, S. C., Kim, J. H., Prasad, S. and Aggarwal, B. B. 2010. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev. 29, 405-434.
DOI
|
20 |
Han, M. H., Kim, S. O., Kim, G. Y., Kwon, T. K., Choi, B. T., Lee, W. H. and Choi, Y. H. 2007. Induction of apoptosis by sanguinarine in C6 rat glioblastoma cells is associated with the modulation of the Bcl-2 family and activation of caspases through downregulation of extracellular signal-regulated kinase and Akt. Anticancer Drugs 18, 913-921.
|
21 |
Han, M. H., Park, C., Jin, C. Y., Kim, G. Y., Chang, Y. C., Moon, S. K., Kim, W. J. and Choi, Y. H. 2013. Apoptosis induction of human bladder cancer cells by sanguinarine through reactive oxygen species-mediated up-regulation of early growth response gene-1. PLoS One 8, e63425.
DOI
|
22 |
Han, M. H., Kim, G. Y., Yoo, Y. H. and Choi, Y. H. 2013. Sanguinarine induces apoptosis in human colorectal cancer HCT-116 cells through ROS-mediated Egr-1 activation and mitochondrial dysfunction. Toxicol. Lett. 220, 157-166.
DOI
|
23 |
Hu, L., Hofmann, J., Lu, Y., Mills, G. B. and Jaffe, R. B. 2002. Inhibition of phosphatidylinositol 3'-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models. Cancer Res. 62, 1087-1092.
|
24 |
Dong, X. Z., Zhang, M., Wang, K., Liu, P., Guo, D. H., Zheng, X. L. and Ge, X. Y. 2013. Sanguinarine inhibits vascular endothelial growth factor release by generation of reactive oxygen species in MCF-7 human mammary adenocarcinoma cells. Biomed. Res. Int. 2013, 517698.
|
25 |
Jeong, S. Y. and Seol, D. W. 2008. The role of mitochondria in apoptosis. BMB Rep. 41, 1122.
|
26 |
Jin, Z. and El-Deiry, W. S. 2005. Overview of cell death signaling pathways. Cancer Biol. Ther. 4, 139-163.
|
27 |
Degli Esposti, M. and Dive, C. 2003. Mitochondrial membrane permeabilisation by Bax/Bak. Biochem. Biophys. Res.Commun. 304, 455-461.
DOI
|
28 |
Duriez, P. J. and Shah, G. M. 1997. Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death. Biochem. Cell. Biol. 75, 337-349.
DOI
|
29 |
Duvoix, A., Delhalle, S., Blasius, R., Schnekenburger, M., Morceau, F., Fougère, M., Henry, E., Galteau, M. M., Dicato, M. and Diederich, M. 2004. Effect of chemopreventive agents on glutathione S-transferase P1-1 gene expression mechanisms via activating protein 1 and nuclear factor kappaB inhibition. Biochem. Pharmacol. 68, 1101-1111.
DOI
|
30 |
Fulda, S. and Debatin, K. M. 2006. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25, 4798-4811.
DOI
|
31 |
Gatti, L., Cossa, G., Tinelli, S., Carenini, N., Arrighetti, N., Pennati, M., Cominetti, D., De Cesare, M., Zunino, F.,Zaffaroni, N. and Perego, P. 2014. Improved apoptotic cell death in drug-resistant non-small-cell lung cancer cells by tumor necrosis factor-related apoptosis-inducing ligandbased treatment. J. Pharmacol. Exp. Ther. 348, 360-371.
DOI
|
32 |
Godowski, K. C. 1989. Antimicrobial action of sanguinarine. J. Clin. Dent. 1, 96-101.
|
33 |
Choi, W. Y., Jin, C. Y., Han, M. H., Kim, G. Y., Kim, N. D., Lee, W. H., Kim, S. K. and Choi, Y. H. 2009. Sanguinarine sensitizes human gastric adenocarcinoma AGS cells to TRAIL-mediated apoptosis via down-regulation of AKT and activation of caspase-3. Anticancer Res. 29, 4457-4465.
|
34 |
Gu, S., Yang, X. C., Xiang, X. Y., Wu, Y., Zhang, Y., Yan, X. Y., Xue, Y. N., Sun, L. K. and Shao, G. G. 2015. Sanguinarine-induced apoptosis in lung adenocarcinoma cells is dependent on reactive oxygen species production and endoplasmic reticulum stress. Oncol. Rep. 34, 913-919.
|
35 |
Brenner, D. and Mak, T. W. 2009. Mitochondrial cell death effectors. Curr. Opin. Cell Biol. 21, 871-877.
DOI
|
36 |
Choi, W. Y., Kim, G. Y., Lee, W. H. and Choi, Y. H. 2008. Sanguinarine, a benzophenanthridine alkaloid, induces apoptosis in MDA-MB-231 human breast carcinoma cells through a reactive oxygen species-mediated mitochondrial pathway. Chemotherapy 54, 279-287.
DOI
|
37 |
Choi, Y. H., Choi, W. Y., Hong, S. H., Kim, S. O., Kim, G. Y., Lee, W. H. and Yoo, Y. H. 2009. Anti-invasive activity of sanguinarine through modulation of tight junctions and matrix metalloproteinase activities in MDA-MB-231 human breast carcinoma cells. Chem. Biol. Interact. 179, 185-191.
DOI
|
38 |
Circu, M. L. and Aw, T. Y. 2001. Reactive oxygen species, cellular redox systems, and apoptosis. Free. Radic. Biol. Med. 48, 749-762.
|
39 |
De Stefano, I., Raspaglio, G., Zannoni, G. F., Travaglia, D., Prisco, M. G., Mosca, M., Ferlini, C., Scambia, G. and Gallo, D. 2009. Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma. Biochem. Pharmacol. 78, 1374-1381.
DOI
|
40 |
Bassi, R., Heads, R., Marber, M. S. and Clark, J. E. 2008. Targeting p38-MAPK in the ischaemic heart: kill or cure? Curr. Opin. Pharmacol. 8, 141-146.
DOI
|
41 |
Basini, G., Santini, S. E., Bussolati, S. and Grasselli, F. 2007. Sanguinarine inhibits VEGF-induced Akt phosphorylation. Ann. N. Y. Acad. Sci. 1095, 371-376.
DOI
|
42 |
Bedner, E., Li, X., Gorczyca, W., Melamed, M. R. and Darzynkiewicz, Z. 1999. Analysis of apoptosis by laser scanning cytometry. Cytometry 35, 181-195.
DOI
|
43 |
Adhami, V. M., Aziz, M. H., Mukhtar, H. and Ahmad, N. 2003. Activation of prodeath Bcl-2 family proteins and mitochondrial apoptosis pathway by sanguinarine in immortalized human HaCaT keratinocytes. Clin. Cancer Res. 9, 3176-3182.
|
44 |
Ahsan, H., Reagan-Shaw, S., Breur, J. and Ahmad, N. 2007. Sanguinarine induces apoptosis of human pancreatic carcinoma AsPC-1 and BxPC-3 cells via modulations in Bcl-2 family proteins. Cancer Lett. 249, 198-208.
DOI
|
45 |
Xu, J. Y., Meng, Q. H., Chong, Y., Jiao, Y., Zhao, L., Rosen, E. M. and Fan, S. 2013. Sanguinarine is a novel VEGF inhibitor involved in the suppression of angiogenesis and cell migration. Mol. Clin. Oncol. 1, 331-336.
|